Cargando…
Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use?
SIMPLE SUMMARY: Cancer is largely caused by genetic alterations such as mutations in a group of genes known as cancer driver genes. Many of the key advances in cancer treatment in recent years have involved blocking these driver genes using a new generation of anti-cancer drugs. Although p53 is the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496879/ https://www.ncbi.nlm.nih.gov/pubmed/36139658 http://dx.doi.org/10.3390/cancers14184499 |